The University of Texas MD Anderson Cancer Center in Houston and MedImmune, the bioresearch development subsidiary of AstraZeneca, have entered into a collaborative effort to develop new cancer immunotherapies, MD Anderson announced yesterday.

Neuroendocrine tumor imaging just got a boost with both U.S Food and Drug Administration (FDA) and European Medicines Agency (EMA) orphan drug designation for gallium-68 DOTATATE, used in PET imaging of neuroendocrine cancer.

Limiting breast compression during biopsy is recommended, except when clinically necessary, as it affects breast lesion detection, lesion size, and dynamic contrast-enhanced MRI interpretation and performance, according to a study published online Mar. 12 by Radiology. 

Patients with carpal tunnel syndrome (CTS) differ from normal subjects in terms of mobility and deformability of the median nerve, according to a study published in the April issue of Academic Radiology.

Could a home colon cancer test boost screening rates, especially in underserved populations? That was the question asked by researchers at the Kaiser Permanente Center for Health Research.

After waiting patiently for sodium F-18 fluoride PET/CT data to come out of the National Oncological PET Registry (NOPR), clinicians are now clear that that the scan benefits patients by changing their course of care, at the very least, 12 percent of the time, according to a review published March 10 in the Journal of Nuclear Medicine.

A simple blood test has been shown to be highly accurate in predicting the onset of Alzheimer’s disease in otherwise healthy people years before symptom onset.

The Johnson and Johnson Innovation Center is bankrolling a research project with San Francisco-based Alector to prove feasibility of a monoclonal antibody agent that homes in on and treats Alzheimer’s disease processes in the brain, Alector announced yesterday.